Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholecalciferol vs calcifediol in hemodialysis patients with vitamin D deficiency
2019-003101-97Phase 4Active
- Sponsor
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vitamin d and calcifediol in Vitamin D deficiency (VDD) and end-stage kidney disease (ESKD) (2 arms), sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Primary endpoint: Difference in mineral metabolism markers between treatments. Started Dec 2019; status: active.
02
Drugs
vitamin dcalcifediol
03
Conditions
Vitamin D deficiency (VDD)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2019-003101-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003101-97.